← SynDRA
L-778123
SynDRA canonical compound SYN1965392 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | FNTA | FNTB | PGGT1B |
|---|
| Mechanism of action | farnesyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- farnesyltransferase inhibitor
Cross-references
Synonyms
- UNII-31ZXM8ZKQ3
- 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE
- 31ZXM8ZKQ3
- CHEMBL279433
- 4-((5-((4-(3-chlorophenyl)-3-oxopiperazin-1-yl)methyl)-1H-imidazol-1-yl)methyl)benzonitrile
- L-778123 free base
- 4-[[5-[[4-(3-chlorophenyl)-3-oxopiperazin-1-yl]methyl]imidazol-1-yl]methyl]benzonitrile
- 4-[(5-{[4-(3-chlorophenyl)-3-oxopiperazin-1-yl]methyl}imidazol-1-yl)methyl]benzonitrile
- SCHEMBL1683541
- AC1L50Q0
- CTK7C7787
- 1s63
- 1s64
- BDBM50097071
- ZINC53070632
Look up L-778123 in the interactive SynDRA portal →